Connection

Armand Glassman to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Armand Glassman has written about Combined Modality Therapy.
Armand Glassman
Connection Strength
0.013
Combined Modality Therapy
  1. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood. 2005 Jun 15; 105(12):4573-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.